image credit- shutterstock
A wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) has entered into definitive agreements to invest $200 million for an approximately 3% stake in Micro Life Sciences Private Limited (“Meril”), one of India’s leading medical devices companies.
This investment values Meril at an enterprise value of $6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI).
Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specialties — including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics and surgical robotics.
The Abu Dhabi Investment Authority is a globally-diversified investment institution that prudently invests funds on behalf of the Government of Abu Dhabi through a strategy focused on long-term value creation.
